Along similar lines, in an animal study, MOTS-c therapy was administeredto mice with gestational diabetes mellitus, which resulted in a significantimprovement in hyperglycemia, insulin sensitivity, and glucose tolerance (23). The gene discussed is INS; the disease is Hyperglycemia.